JP2014152125A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014152125A5 JP2014152125A5 JP2013021411A JP2013021411A JP2014152125A5 JP 2014152125 A5 JP2014152125 A5 JP 2014152125A5 JP 2013021411 A JP2013021411 A JP 2013021411A JP 2013021411 A JP2013021411 A JP 2013021411A JP 2014152125 A5 JP2014152125 A5 JP 2014152125A5
- Authority
- JP
- Japan
- Prior art keywords
- iga secretion
- secretion promoter
- iga
- promoter according
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000028327 secretion Effects 0.000 claims 8
- 229920001353 Dextrin Polymers 0.000 claims 2
- 239000004375 Dextrin Substances 0.000 claims 2
- 235000019425 dextrin Nutrition 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003266 anti-allergic Effects 0.000 claims 1
- 230000002924 anti-infective Effects 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000003308 immunostimulating Effects 0.000 claims 1
Claims (6)
- 難消化性デキストリンを有効成分とするIgA分泌促進剤。
- 難消化性デキストリンの難消化性成分が４５質量％以上である請求項１記載のIgA分泌促進剤。
- IgA分泌促進剤が経口投与形態の剤形に調製されている請求項１又は２に記載のIgA分泌促進剤。
- 請求項１〜３のいずれか一項に記載のIgA分泌促進剤を含むIgA分泌促進用飲食品組成物。
- 請求項１〜３のいずれか一項に記載のIgA分泌促進剤を含む粘膜免疫賦活剤、抗感染症剤又は抗アレルギー剤。
- 請求項１〜３のいずれか一項に記載のIgA分泌促進剤を含む粘膜免疫賦活用、抗感染症用又は抗アレルギー用飲食品組成物。
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013021411A JP6160011B2 (ja) | 2013-02-06 | 2013-02-06 | ＩｇＡ分泌促進剤 |
| KR1020130040848A KR20140100380A (ko) | 2013-02-06 | 2013-04-15 | IgA 분비 촉진제 |
| TW102113294A TWI598102B (zh) | 2013-02-06 | 2013-04-15 | 使用難消化性糊精在製備IgA分泌促進劑、黏膜免疫活化劑、抗感染症劑及抗過敏劑的用途 |
| US13/871,517 US20140220080A1 (en) | 2013-02-06 | 2013-04-26 | IgA SECRETION PROMOTER |
| KR1020190048192A KR101985644B1 (ko) | 2013-02-06 | 2019-04-25 | 면역 증진제 및 이를 포함하는 면역 개선용 음식품 조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013021411A JP6160011B2 (ja) | 2013-02-06 | 2013-02-06 | ＩｇＡ分泌促進剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014152125A JP2014152125A (ja) | 2014-08-25 |
| JP2014152125A5 true JP2014152125A5 (ja) | 2016-04-07 |
| JP6160011B2 JP6160011B2 (ja) | 2017-07-12 |
Family
ID=51259397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013021411A Active JP6160011B2 (ja) | 2013-02-06 | 2013-02-06 | ＩｇＡ分泌促進剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20140220080A1 (ja) |
| JP (1) | JP6160011B2 (ja) |
| KR (2) | KR20140100380A (ja) |
| TW (1) | TWI598102B (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7359374B2 (ja) | 2017-10-26 | 2023-10-11 | 株式会社ダイセル | 腸管免疫亢進剤、食品、及び医薬 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04179459A (ja) * | 1990-11-13 | 1992-06-26 | Matsutani Kagaku Kogyo Kk | 大腸癌予防作用を有する食品用又は飼料用組成物 |
| JPH05178902A (ja) * | 1991-10-29 | 1993-07-20 | Matsutani Kagaku Kogyo Kk | 難消化デキストリン |
| JP2003201239A (ja) | 2001-11-05 | 2003-07-18 | Meiji Milk Prod Co Ltd | 免疫賦活食品組成物 |
| KR100485154B1 (ko) * | 2002-05-22 | 2005-04-22 | 주식회사 삼양제넥스 | 난소화성 덱스트린을 포함하는 면역활성 조성물 |
| JP2005047829A (ja) * | 2003-07-30 | 2005-02-24 | Taiyo Kagaku Co Ltd | 炎症性腸疾患の予防・治療剤 |
| CN101987107A (zh) * | 2003-10-24 | 2011-03-23 | 努特里奇亚有限公司 | 免疫调节性寡糖 |
| JP4382465B2 (ja) | 2003-12-16 | 2009-12-16 | 三井農林株式会社 | 粘膜免疫賦活剤 |
| JP2005289847A (ja) * | 2004-03-31 | 2005-10-20 | Unitika Ltd | 血糖値上昇抑制剤 |
| EP1629727A1 (en) * | 2004-08-24 | 2006-03-01 | N.V. Nutricia | Composition containing fermentable polysaccharides |
| ES2369789T3 (es) * | 2005-04-21 | 2011-12-07 | The Hokuren Federation Of Agricultural Cooperatives | 1-kestosa para tratar alergias y dermatitis atópica. |
| JP5367228B2 (ja) * | 2007-02-28 | 2013-12-11 | 公立大学法人大阪府立大学 | 腸管免疫賦活化剤及び抗アレルギー剤 |
| JP2010254594A (ja) * | 2009-04-22 | 2010-11-11 | Fujifilm Corp | 腸内バクテロイデス増殖促進剤 |
| JP2011184300A (ja) * | 2010-03-04 | 2011-09-22 | Lotte Co Ltd | イムノグロブリンａ分泌促進剤 |
-
2013
- 2013-02-06 JP JP2013021411A patent/JP6160011B2/ja active Active
- 2013-04-15 KR KR1020130040848A patent/KR20140100380A/ko active Application Filing
- 2013-04-15 TW TW102113294A patent/TWI598102B/zh active
- 2013-04-26 US US13/871,517 patent/US20140220080A1/en not_active Abandoned
-
2019
- 2019-04-25 KR KR1020190048192A patent/KR101985644B1/ko active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014129360A5 (ja) | ||
| JP2014515597A5 (ja) | ||
| PH12015502755A1 (en) | Insulin glargine / lixisenatide fixed ratio formulation | |
| MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
| WO2014007770A3 (en) | Inhalation compositions comprising corticosteroid and sorbitol | |
| EP2682101A3 (en) | Inhalation Compositions Comprising Glucose Anhydrous | |
| WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| WO2014137797A3 (en) | Stable glucokinase activator compositions | |
| IL282032A (en) | Pharmaceutical preparations containing RPL554 in HFA-134A for administration by inhalation | |
| WO2014007781A3 (en) | Inhalation compositions | |
| WO2015001163A3 (es) | Nanopartículas lipídicas para la cicatrización de heridas | |
| EP2682100A3 (en) | Inhalation Compositions Comprising Muscarinic Receptor Antagonist | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| MX360047B (es) | Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación. | |
| EP2682129A3 (en) | Compositions Comprising Muscarinic Receptor Antagonist and Glucose Anhydrous | |
| MX2017014776A (es) | Combinacion farmaceutica de everolimus con dactolisib. | |
| CL2015002702A1 (es) | Composiciones farmacéuticas micronizadas. | |
| MX2015010486A (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
| MX355719B (es) | Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano. | |
| JP2014152125A5 (ja) | ||
| EP2682103A3 (en) | Compositions Comprising Muscarinic Receptor Antagonist and Sorbitol | |
| EA201500694A1 (ru) | Монолитная лекарственная форма для модифицированного высвобождения комбинации активных ингредиентов | |
| JP2017517574A5 (ja) |